Correction: Efficacy and Safety of Ipragliflozin in Japanese Patients With Type 2 Diabetes: Interim Outcome of the ASSIGN-K Study
Takashi Iizuka,Kotaro Iemitsu,Masahiro Takihata,Masahiko Takai,Shigeru Nakajima,Nobuaki Minami,Shinichi Umezawa,Akira Kanamori,Hiroshi Takeda,Takehiro Kawata,Shogo Ito,Taisuke Kikuchi, Hikaru Amemiya,Mizuki Kaneshiro,Atsuko Mokubo,Tetsuo Takuma,Hideo Machimura,Keiji Tanaka,Taro Asakura,Akira Kubota, Sachio Aoyagi, Kazuhiko Hoshino,Masashi Ishikawa,Yoko Matsuzawa,Mitsuo Obana, Nobuo Sasai,Hideaki Kaneshige,Fuyuki Minagawa,Tatsuya Saito,Kazuaki Shinoda,Masaaki Miyakawa,Yasushi Tanaka,Yasuo Terauchi,Ikuro Matsuba Journal of Clinical Medicine Research(2016)
AI 理解论文
溯源树
样例